Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing

Stock Information for Microbix Biosystems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Microbix Biosystems Inc.

Microbix Updates Investor Presentation on its Website
Microbix Reports Results for Q4 and Fiscal 2025
Microbix Schedules Release of Results for Q4 Fiscal 2025
Microbix Launches New Products to Support H3N2 Flu Testing
Microbix Announces Initiation of Normal Course Issuer Bid
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests
Microbix Addresses Cybersecurity Incident

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.